Free Trial

Rapid Micro Biosystems (RPID) Competitors

Rapid Micro Biosystems logo
$3.60 +0.10 (+2.71%)
Closing price 03:59 PM Eastern
Extended Trading
$3.60 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RPID vs. LAB, CTKB, SENS, QSI, FEIM, MASS, QTRX, PRE, OWLT, and SEER

Should you be buying Rapid Micro Biosystems stock or one of its competitors? The main competitors of Rapid Micro Biosystems include Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quantum-Si (QSI), Frequency Electronics (FEIM), 908 Devices (MASS), Quanterix (QTRX), Prenetics Global (PRE), Owlet (OWLT), and Seer (SEER). These companies are all part of the "measuring and control equipment" industry.

Rapid Micro Biosystems vs. Its Competitors

Rapid Micro Biosystems (NASDAQ:RPID) and Standard BioTools (NASDAQ:LAB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

Standard BioTools has a net margin of -69.08% compared to Rapid Micro Biosystems' net margin of -145.63%. Standard BioTools' return on equity of -20.23% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Rapid Micro Biosystems-145.63% -63.07% -48.33%
Standard BioTools -69.08%-20.23%-15.32%

52.6% of Rapid Micro Biosystems shares are owned by institutional investors. Comparatively, 53.7% of Standard BioTools shares are owned by institutional investors. 30.0% of Rapid Micro Biosystems shares are owned by company insiders. Comparatively, 23.2% of Standard BioTools shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Rapid Micro Biosystems has higher earnings, but lower revenue than Standard BioTools. Standard BioTools is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rapid Micro Biosystems$30.29M5.27-$46.89M-$1.01-3.57
Standard BioTools$172.27M3.03-$138.88M-$0.32-4.27

Rapid Micro Biosystems has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. Comparatively, Standard BioTools has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500.

Rapid Micro Biosystems currently has a consensus target price of $8.00, suggesting a potential upside of 121.61%. Standard BioTools has a consensus target price of $1.55, suggesting a potential upside of 13.55%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, analysts clearly believe Rapid Micro Biosystems is more favorable than Standard BioTools.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67
Standard BioTools
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.75

In the previous week, Rapid Micro Biosystems had 1 more articles in the media than Standard BioTools. MarketBeat recorded 3 mentions for Rapid Micro Biosystems and 2 mentions for Standard BioTools. Rapid Micro Biosystems' average media sentiment score of 1.05 beat Standard BioTools' score of 0.00 indicating that Rapid Micro Biosystems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rapid Micro Biosystems
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Standard BioTools
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Rapid Micro Biosystems beats Standard BioTools on 11 of the 17 factors compared between the two stocks.

Get Rapid Micro Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RPID vs. The Competition

MetricRapid Micro BiosystemsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$159.82M$6.92B$9.05B$10.58B
Dividend YieldN/A1.16%5.69%4.71%
P/E Ratio-3.5827.4185.8427.32
Price / Sales5.27194.92535.95201.92
Price / CashN/A21.7337.9261.55
Price / Book2.065.3613.026.76
Net Income-$46.89M$178.04M$3.30B$275.79M
7 Day Performance2.27%4.38%4.69%2.44%
1 Month Performance35.71%12.30%9.86%8.86%
1 Year Performance305.62%33.33%84.90%35.45%

Rapid Micro Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RPID
Rapid Micro Biosystems
3.1713 of 5 stars
$3.61
+3.1%
$8.00
+121.6%
+288.9%$159.82M$30.29M-3.58200News Coverage
Positive News
Analyst Forecast
LAB
Standard BioTools
1.9921 of 5 stars
$1.27
-2.3%
$1.55
+22.0%
-26.7%$496.59M$172.27M-3.97620News Coverage
Positive News
Analyst Forecast
CTKB
Cytek Biosciences
2.4693 of 5 stars
$3.38
-0.6%
$5.60
+65.7%
-22.6%$432.56M$200.45M-67.60500News Coverage
Positive News
Analyst Upgrade
SENS
Senseonics
2.3349 of 5 stars
$0.44
-3.8%
$1.54
+247.5%
+37.5%$360.50M$25.47M-3.4090News Coverage
Gap Up
QSI
Quantum-Si
2.5029 of 5 stars
$1.39
-6.7%
$3.48
+150.0%
+111.4%$301.72M$3.06M-2.04150Analyst Forecast
Gap Down
FEIM
Frequency Electronics
2.0325 of 5 stars
$32.09
+6.6%
$43.00
+34.0%
+215.3%$293.55M$69.81M14.01200Positive News
Analyst Forecast
MASS
908 Devices
1.8483 of 5 stars
$8.15
+1.7%
$8.00
-1.8%
+162.9%$287.25M$59.63M-15.0960Analyst Forecast
QTRX
Quanterix
1.7835 of 5 stars
$5.25
+1.2%
$11.75
+123.8%
-47.6%$241.16M$137.42M-2.88460News Coverage
Positive News
Analyst Forecast
PRE
Prenetics Global
1.0014 of 5 stars
$13.59
+8.1%
$9.00
-33.8%
+253.5%$163.22M$57.05M-3.411News Coverage
Analyst Forecast
OWLT
Owlet
1.914 of 5 stars
$8.45
-2.9%
$10.25
+21.3%
+114.1%$148.56M$78.10M-2.41106Analyst Forecast
SEER
Seer
0.9112 of 5 stars
$2.21
-2.6%
N/A+16.0%$127.89M$14.17M-1.59160Analyst Forecast

Related Companies and Tools


This page (NASDAQ:RPID) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners